Drug makers struggle to create key products of 10 billion won sales.

Published: 2004-05-11 06:59:00

Updated: 2004-05-11 06:59:00

Leading domestic pharmaceutical firms are trying to create their key products at the level of 10 billion won sales in order to generate their stable revenue and income, after fully realizing that the company hardly overcome the protracted pharmaceutical economic recession and achieve sales target...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK